Advanced Search

 

Study ID Status Title Patient Level Data
204787 Terminated Determination of SPF, before and after (40 and 80 minutes) of immersion in water, for a cosmetic product
204788 Terminated Determination of SPF, before and after (40 and 80 minutes) of immersion in water, for a cosmetic product
204789 Terminated Determination of SPF, before and after (40 and 80 minutes) of immersion in water, for a cosmetic product
204790 Terminated Determination of SPF, before and after (40 and 80 minutes) of immersion in water, for a cosmetic product
204791 Completed Determination of UVA Protection Factor (UVAPF) for a cosmetic product
204792 Completed Determination of UVA Protection Factor (UVAPF) for a cosmetic product
204799 Terminated Determination of SPF, before and after (40 and 80 minutes) of immersion in water, for a cosmetic product
204800 Terminated Determination of SPF, before and after (40 and 80 minutes) of immersion in water, for a cosmetic product
204813 Completed An observer-blind safety and reactogenicity study to assess GlaxoSmithKline (GSK) Biologicals’ investigational respiratory syncytial virus (RSV) vaccine (GSK3003891A) in healthy women
204833 Completed Integrated analysis to estimate of the duration of protection provided by GSK’s hepatitis A and B vaccine Twinrix™ administered in healthy adults in a 0-1-6 schedule, based on the 20-year follow-up results of studies HAB-028 and HAB-032.
204853 Completed A Microdose Study to Describe the Intravenous Pharmacokinetics of GSK3191607 in Healthy Male Subjects Following Administration of [14C]-GSK3191607
204870 Completed A Clinical Study to Evaluate the Efficacy of an Experimental Mouthwash Formulation
204900 Completed PGx7642: Meta-analysis of data from FCGR PGx evaluations of ofatumumab CLL studies OMB110911, OMB114242, OMB115991 and OMB110913
204901 Completed PGx7644: Meta-analysis of data from SLE patients treated with Benlysta in studies BEL112341, BEL110752/BLISS-52/C1056, and BEL110751/BLISS-76/C1057
204927 Completed PGx7643: Efficacy pharmacogenetic analysis of SLE patients treated with Benlysta in study BEL112341
204953 Completed A Double-Blind (Sponsor Unblinded), Randomized, Placebo-Controlled, Continuation Single and Repeated Dose Escalation Study to Investigate the Safety, Tolerability and Pharmacokinetics of GSK2838232 with Ritonavir, in Healthy Subjects
204983 Completed An open-label study to evaluate the preference attributes of the ELLIPTA™ dry powder inhaler (DPI) compared to the HandiHaler™ DPI in subjects with Chronic Obstructive Pulmonary Disease (COPD)
204999 Terminated Comparative Effectiveness of Belimumab Use among SLE Patients in a Commercially Insured US Population: 2010-2014
205024 Completed Skin Acceptability Assessment of 874A in subjects with sensitive skin Under Normal Usage Conditions
205033 Completed A Randomized, Open-Label, Two-Period, Crossover Bioequivalence Study in Healthy Adult Subjects after Single Oral Dosing of a NCH-GSK Acetylcysteine 2% Oral Solution versus a Reference Fluimucil® Acetylcysteine 2% Oral Solution
205034 Completed An open label study to assess the warming sensation, acceptability and local oral tolerability of NCH-GSK Acetylcysteine 2% Oral Solution, given as a single dose in subjects suffering from productive cough due to upper respiratory tract infection
205034 Completed An open label study to assess the warming sensation, acceptability and local oral tolerability of NCH-GSK Acetylcysteine 2% Oral Solution, given as a single dose in subjects suffering from productive cough due to upper respiratory tract infection
205035 Completed A randomized, single-center, crossover, comparative bioavailability and adhesion performance study, comparing single administrations of a new scopolamine transdermal delivery system formulation to the currently established reference transdermal delivery system in healthy adult participants.
205045 Completed A clinical study investigating the Gingivitis Efficacy of a Stannous Fluoride Dentifrice
205051 Completed A Study to Investigate the Antimicrobial Activity of two Test Toothpastes in a Plaque Glycolysis and Regrowth Model

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.